Effects of Three Dimensional Microenvironment on Tumorigenicity of Fibrosarcoma in vitro

Authors

  • Irit Levinger Avram and Stella Goldstein-Goren, Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel
  • Racheli Zagouri Avram and Stella Goldstein-Goren, Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel
  • Yvonne Ventura Avram and Stella Goldstein-Goren, Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel
  • Razi Vago Avram and Stella Goldstein-Goren, Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel

DOI:

https://doi.org/10.17140/CSMMOJ-1-103

Keywords:

MicroenvironmentV, Tumorigenicity, Fibrosarcoma

Abstract

Tumor microenvironment plays an important role in cancer progression owing to interactions between the tumor and adjoining cells and, as in bone marrow, the unique architecture and chemical compounds that characterize it. It has recently been proposed that
bone marrow shelters cancer cells in niches which may favor regulation of their quiescence, although the mechanisms involved have yet to be elucidated. We conjectured that a bone marrow mimicking, calcium providing 3D biolattice recently developed by our group could affect fibrosarcoma cells in various ways, whether via its specific architecture or due to its provision of calcium, an element correlated with many tumorgenic processes. In order to verify our conjecture, we examined the modifications induced in fibrosarcoma cells by this biolattice. We found that its regulatory effects on fibrosarcomas enhanced tumorigenicity, mediated by up-regulated tumorigenesis related genes. We observed decreased proliferation of cancer cells accompanied by up-regulation of genes associated with cancer stem cells, pointing to a process of de-differentiation. In addition, our results revealed up-regulation of Wnt4 and c-Myc in cells cultured on the biolattice, along with down-regulation of AXIN-1 and WIF-1. Taken together these findings suggest that a calcium rich bone marrow-like microenvironment can affect the tumorigenic capacity and fibrosarcoma cells de-differentiation through the mediation of the Wnt signaling pathway.

References

Pedersen EA, Shiozawa Y, Pienta KJ, Taichman RS. The prostate cancer bone marrow niche: More than just ‘fertile soil’. Asian J Androl. 2012; 14: 423-427. doi: 10.1038/aja.2011.164

Santini D, Pantano F, Vincenzi B, Tonini G, Bertoldo F. The role of bone microenvironment, vitamin D and calcium. Recent Results Cancer Res. 2012; 192: 33-64. doi: 10.1007/978-3-642- 21892-7_2

Fischbach C, Kong HJ, Hsiong SX, Evangelista MB, Yuen W, Mooney DJ. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci U. S. A. 2009; 106: 399-404. doi: 10.1073/pnas.0808932106

Albini A, Sporn MB. The tumour microenvironment as a tar-get for chemo prevention. Nat Rev Cancer. 2007; 139-147. doi: 10.1038/nrc2067

Beacham DA, Cukierman E. Stromagenesis: The changing face of fibroblastic microenvironments during tumor progres-sion. Semin Cancer Biol. 2005; 15: 329-341. doi: 10.1016/j. semcancer.2005.05.003

Bissell MJ, Radisky DC, Rizki A, Weaver VM, Petersen OW. The organizing principle: Microenvironmental influences in the normal and malignant breast. Differentiation. 2002; 70: 537- 546. doi: 10.1046/j.1432-0436.2002.700907.x

Zeromski J, Nyczak E, Dyszkiewicz W. Significance of cell adhesion molecules, CD56/NCAM in particular, in human tu-mor growth and spreading. Folia Histochem Cytobiol. 2001; 39 Suppl 2: 36-37.

Tilghman RW, Cowan CR, Mih JD, et al. Matrix rigidity regulates cancer cell growth and cellular phenotype. PLoS One. 2010; 5: e12905. doi: 10.1371/journal.pone.0012905

Cullen PJ, Lockyer PJ. Integration of calcium and ras signal-ling. Nat Rev Mol Cell Biol. 2002; 3: 339-348. doi: 10.1038/ nrm808

Davis FM, Azimi I, Faville RA, et al. Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. Oncogene. 2013. doi: 10.1038/onc.2013.187

Monteith GR, Davis FM, Roberts-Thomson SJ. Calcium channels and pumps in cancer: Changes and consequenc-es, J Biol Chem. 2012; 287: 31666-31673. doi: 10.1074/jbc. R112.343061

Mishra SK, Siddique HR, Saleem M. S100A4 calcium-binding protein is key player in tumor progression and metas-tasis: Preclinical and clinical evidence. Cancer Metastasis Rev. 2012; 31: 163-172. doi: 10.1007/s10555-011-9338-4

Sack U, Walther W, Scudiero D, et al. S100A4-induced cell motility and metastasis is restricted by the Wnt/beta-catenin pathway inhibitor calcimycin in colon cancer cells. Mol Biol Cell. 2011; 22: 3344-3354. doi: 10.1091/mbc.E10-09-0739

Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100: 57-70. doi: http://dx.doi.org/10.1016/S0092-8674- (00)81683-9

Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011; 144: 646-674. doi: 10.1016/j. cell.2011.02.013

Boye K, Maelandsmo GM. S100A4 and metastasis: A small actor playing many roles. Am J Pathol. 2010; 176: 528-535. doi: 10.2353/ajpath.2010.090526

Capiod T. The need for calcium channels in cell pro-liferation, Recent Pat Anticancer Drug Discov. 2012. doi: 10.2174/1574892811308010004

Peinado H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol. 2004; 48: 365-375. doi: 10.1387/ijdb.041794hp

Nakamura T, Kato Y, Fuji H, Horiuchi T, Chiba Y, Tana-ka K. E-cadherin-dependent intercellular adhesion enhanc-es chemoresistance. Int J Mol Med. 2003; 12: 693-700. doi: 10.3892/ijmm.12.5.693

Nguyen PT, Kudo Y, Yoshida M, Kamata N, Ogawa I, Taka-ta T. N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition. Histol Histopathol. 2011; 26: 147-156.

Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006; 127: 469-480. doi: http://dx.doi. org/10.1016/j.cell.2006.10.018

Nelson WJ, Nusse R. Convergence of wnt, beta-catenin, and cadherin pathways. Science. 2004; 303: 1483-1487. doi: 10.1126/science.1094291

Dang CV, O’Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. The c-myc target gene network. Semin Cancer Biol. 2006; 16: 253-264. doi: 10.1016/j.semcancer.2006.07.014

O’Donnell KA, Yu D, Zeller KI, et al. Activation of trans-ferrin receptor 1 by c-myc enhances cellular proliferation and tu-morigenesis. Mol Cell Biol. 2006; 26: 2373-2386. doi: 10.1128/ MCB.26.6.2373-2386.2006

Clevers H, Batlle E. EphB/EphrinB receptors and wnt sig-naling in colorectal cancer. Cancer Res. 2006; 66: 2-5. doi: 10.1158/0008-5472.CAN-05-3849

Klarmann GJ, Decker A, Farrar WL. Epigenetic gene silenc-ing in the wnt pathway in breast cancer. Epigenetics. 2008; 3: 59-63. doi: 10.4161/epi.3.2.5899

Barham W, Frump AL, Sherrill TP, et al, Targeting the wnt pathway in synovial sarcoma models. Cancer Discov. 2013; 3: 1286-1301. doi: 10.1158/2159-8290.CD-13-0138

Vijayakumar S, Liu G, Rus IA, et al. High-frequency canoni-cal wnt activation in multiple sarcoma subtypes drives prolifera-tion through a TCF/beta-catenin target gene, CDC25A. Cancer Cell. 2011; 19: 601-612. doi: 10.1016/j.ccr.2011.03.010

Guo Y, Xie J, Rubin E, et al. Frzb, a secreted wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells asso-ciated with inhibition of met signaling. Cancer Res. 2008; 68: 3350-3360. doi: 10.1158/0008-5472.CAN-07-3220

Travlos GS. Normal structure, function, and histology of the bone marrow. Toxicol Pathol. 2006; 34: 548-565. doi: 10.1080/01926230600939856

Ronziere MC, Perrier E, Mallein-Gerin F, Freyria AM. Chon-drogenic potential of bone marrow - and adipose tissue-derived adult human mesenchymal stem cells. Biomed Mater Eng. 2010; 20: 145-158. doi: 10.3233/BME-2010-0626

Anjos-Afonso F, Bonnet D. Isolation, culture, and differen-tiation potential of mouse marrow stromal cells. Curr Protoc Stem Cell Biol. 2008; 2: 2B.3. doi: 10.1002/9780470151808. sc02b03s7

Levinger I, Ventura Y, Vago R. Life is three dimensional-as in vitro cancer cultures should be. Adv Cancer Res. 2014; 121: 383-414. doi: 10.1016/B978-0-12-800249-0.00009-3

Kim JB, Stein R, O’Hare MJ. Tumour-stromal interactions in breast cancer: The role of stroma in tumourigenesis. Tumour Biol. 2005; 26: 173-185.

Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003; 3: 537-549.

Maguer-Satta V. The Stem Cell Niche: The black Master of Cancer, S. Shostak (Ed.), Cancer Stem Cells Theories and Practice, CC BY-NC-SA. Website: http://www.intechopen. com/books/howtoreference/cancer-stem-cells-theories-and-practice/the-stem-cell-niche-the-black-master-of-cancer. 2001; 216.

Abarrategi A, Marinas-Pardo L, Mirones I, Rincon E, Gar-cia-Castro J. Mesenchymal niches of bone marrow in cancer. Clin Transl Oncol. 2011; 13: 611-616. doi: 10.1007/s12094- 011-0706-x

Chen L, Xiao Z, Meng Y. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials. 2012; 33: 1437-1444. doi: 10.1016/j.biomaterials.2011.10.056

Pathi SP, Kowalczewski C, Tadipatri R, Fischbach C. A novel 3-D mineralized tumor model to study breast cancer bone metastasis. PLoS One. 2010; 5: e8849.

Morales J, Alpaugh ML. Gain in cellular organization of inflammatory breast cancer: A 3D in vitro model that mim-ics the in vivo metastasis. BMC Cancer. 2009; 9: 462. doi: 10.1186/1471-2407-9-462

Abramovitch-Gottlib L, Geresh S, Vago R. Biofabricated marine hydrozoan: A bioactive crystalline material promoting ossification of mesenchymal stem cells. Tissue Eng. 2006; 12: 729-739. doi: 10.1089/ten.2006.12.729

Vago R. Beyond the skeleton: Cnidarian biomaterials as bioactive extracellular microenvironments for tissue engineer-ing. Organogenesis. 2008; 4: 18-22. doi: 10.4161/org.5843

Bergfeld SA, DeClerck YA. Bone marrow-derived mesen-chymal stem cells and the tumor microenvironment. Cancer Metastasis Rev. 2010; 29: 249-261. doi: 10.1007/s10555-010- -9222-7

Lin R, Wang S, Zhao RC. Exosomes from human adipose-derived mesenchymal stem cells promote migration through wnt signaling pathway in a breast cancer cell model. Mol Cell Biochem. 2013. doi: 10.1007/s11010-013-1746-z

De Luca A, Lamura L, Gallo M, Maffia V, Normanno N. Mesenchymal stem cell-derived interleukin-6 and vascular en-dothelial growth factor promote breast cancer cell migration. J Cell Biochem. 2012; 113: 3363-3370. doi: 10.1002/jcb.24212

Velasco-Velazquez M, Jiao X, De La Fuente M, et al. CCR5 antagonist blocks metastasis of basal breast cancer cells. Cancer Res. 2012; 72: 3839-3850. doi: 10.1158/0008-5472. CAN-11-3917

Wang SW, Wu HH, Liu SC, et al. CCL5 and CCR5 interac-tion promotes cell motility in human osteosarcoma. PLoS One. 2012; 7: e35101. doi: 10.1371/journal.pone.0035101

Wang J, He Q, Shao YG, Ji M. Chemokines fluctuate in the progression of primary breast cancer. Eur Rev Med Pharmacol Sci. 2013: 17: 596-608.

Yoshimura T, Howard OM, Ito T, et al. Monocyte chemoat-tractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PLoS One. 2013; 8: e58791. doi: 10.1371/journal.pone.0058791

Gross-Aviv T, Vago R. The role of aragonite matrix surface chemistry on the chondrogenic differentiation of mesenchymal stem cells. Biomaterials. 2009; 30: 770-779. doi: 10.1016/j. biomaterials.2008.10.026

Andreeff M, Goodrich D, Pardee A. Holland-Frei Cancer Medicine - Cell Proliferation, Differentiation, and Apoptosis. In: Bast RC Jr, Kufe DW, Pollock RE, et al. ed. Holland-Frei Cancer Medicine. 5th Ed, ON, Canada: BC Decker; 2000: Chap2.

Birk RZ, Abramovitch-Gottlib L, Margalit I, et al. Conver-sion of adipogenic to osteogenic phenotype using crystalline po-rous biomatrices of marine origin. Tissue Eng. 2006; 12: 21-31. doi: 10.1089/ten.2006.12.21

Schoenhals M, Kassambara A, De Vos J, Hose D, Moreaux J, Klein B. Embryonic stem cell markers expression in can-cers. Biochem Biophys Res Commun. 2009; 383: 157-162. doi: 10.1016/j.bbrc.2009.02.156

Xiang R, Liao D, Cheng T, et al. Downregulation of tran-scription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer. 2011; 104: 1410- 1417. doi: 10.1038/bjc.2011.94

Chen S, Xu Y, Chen Y, et al. SOX2 gene regulates the tran-scriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS One. 2012; 7: e36326. doi: 10.1371/journal.pone.0036326

Yu D, Jin CS, Chen O, Wen LJ, Gao LF. Biological charac-teristics of highly tumorigenic CD44+CD133+ subpopulation of laryngeal carcinoma cells. Zhonghua Zhong Liu Za Zhi. 2009; 31: 99-103.

Du L, Wang H, He L, et al. CD44 is of functional impor-tance for colorectal cancer stem cells. Clin Cancer Res. 2008; 14: 6751-6760. doi: 10.1158/1078-0432.CCR-08-1034

Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006; 12: 1167-1174. doi: 10.1038/nm1483

Krause DS, Lazarides K, von Andrian UH, Van Etten RA. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med. 2006; 12: 1175-1180. doi: 10.1038/nm1489

Yi SY, Hao YB, Nan KJ, Fan TL. Cancer stem cells niche: A target for novel cancer therapeutics. Cancer Treat Rev. 2012. doi: 10.1016/j.ctrv.2012.10.004

Karamboulas C, Ailles L. Developmental signaling path-ways in cancer stem cells of solid tumors. Biochim Biophys Acta. 2012. doi: 10.1016/j.bbagen.2012.11.008

Samardzija C, Quinn M, Findlay JK, Ahmed N. Attributes of Oct 4 in stem cell biology: Perspectives on cancer stem cells of the ovary. J Ovarian Res. 2012; 5: 37. doi: 10.1186/1757- 2215-5-37

Sugihara E, Saya H. Complexity of cancer stem cells. Int J Cancer. 2012. doi: 10.1002/ijc.27961

Klarmann GJ, Hurt EM, Mathews LA, et al. Invasive pros-tate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Exp Metastasis. 2009; 26: 433- 446. doi: 10.1007/s10585-009-9242-2

Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progres-sion. Curr Opin Cell Biol. 2005; 17: 548-558. doi: 10.1016/j. ceb.2005.08.001

Asano K, Duntsch CD, Zhou Q. Correlation of N-cadherin expression in high grade gliomas with tissue invasion.J Neuroon-col. 2004; 70: 3-15. doi: 10.1023/B:NEON.0000040811.14908. f2

Downloads

Published

2014-11-06

How to Cite

Irit Levinger, Racheli Zagouri, Yvonne Ventura, & Razi Vago. (2014). Effects of Three Dimensional Microenvironment on Tumorigenicity of Fibrosarcoma in vitro. Cancer Studies and Molecular Medicine , 1(1), 16–26. https://doi.org/10.17140/CSMMOJ-1-103

Issue

Vol. 1 No. 1 (2014): Volume 1 Issue 1 2014

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Cancer Studies and Molecular Medicine (CSMM) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.